Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why CRISPR Therapeutics Stock Fell 10.4% Last Month

TheMotleyFool

0 0

Why CRISPR Therapeutics Stock Fell 10.4% Last Month

Shares of CRISPR Therapeutics (NASDAQ: CRSP) fell 10.4% in September, according to data from S&P Global Market Intelligence. There wasn't any business-specific news driving the sell-off, but the gene-editing company's stock got pinched as investors moved out of relatively speculative growth-dependent plays.